Reply to: Hyperuricemia does not seem to be an independent risk factor for coronary heart disease
- PMID: 29140791
- DOI: 10.1515/cclm-2017-0954
Reply to: Hyperuricemia does not seem to be an independent risk factor for coronary heart disease
Keywords: coronary heart disease; meta-analysis; uric acid.
Comment on
-
Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis.Clin Chem Lab Med. 2016 Jan;54(1):7-15. doi: 10.1515/cclm-2015-0523. Clin Chem Lab Med. 2016. PMID: 26351943
-
Hyperuricemia does not seem to be an independent risk factor for coronary heart disease.Clin Chem Lab Med. 2018 Feb 23;56(3):e59-e62. doi: 10.1515/cclm-2017-0487. Clin Chem Lab Med. 2018. PMID: 28917080 No abstract available.
References
-
- Battaggia A, Scalisi A, Puccetti L. Hyperuricemia does not seem to be an independent risk factor for coronary heart disease. Clin Chem Lab Med 22018;56:e59–62.
-
- Braga F, Pasqualetti S, Ferraro S, Panteghini M. Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis. Clin Chem Lab Med 2016;54:7–15.
-
- Pieper D, Mathes T, Eikermann M. Can AMSTAR also be applied to systematic reviews of non-randomized studies? BMC Res Notes 2014;7:609.
-
- Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007;7:10.
-
- Faggion CM Jr. Critical appraisal of AMSTAR: challenges, limitations, and potential solutions from the perspective of an assessor. BMC Med Res Methodol 2015;15:63.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources